Get started
Author

Magdalena Ewa Tyburczy

Observed names: M. E. Tyburczy, M. Tyburczy, Magdalena E Tyburczy, Magdalena E. Tyburczy, Magdalena Tyburczy
ORCID: 0009-0009-8858-527X
Observed ORCID: 0009-0009-8858-527X
OpenAlex ID: A5059393228
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
2015 · Magdalena E. Tyburczy, Kira A. Dies, et al. · PLoS Genetics · 298
PDF
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2016 · David J. Kwiatkowski, Toni K. Choueiri, et al. · Clinical Cancer Research · 230
PDF
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
2016 · Krinio Giannikou, Izabela A. Malinowska, et al. · PLoS Genetics · 129
PDF
Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex
2013 · M. E. Tyburczy, J.-a. Wang, et al. · Human Molecular Genetics · 94
Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic Implications
2010 · Magdalena Ewa Tyburczy, Katarzyna Kotulska, et al. · American Journal Of Pathology · 84
PDF
Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission
2019 · Krinio Giannikou, Kathryn D. Lasseter, et al. · Genetics in Medicine · 60
PDF
A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex
2014 · M. E. Tyburczy, S. Jozwiak, et al. · Human Molecular Genetics · 59
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation
2016 · Juxiang Cao, Magdalena E. Tyburczy, et al. · Journal of Clinical Investigation · 57
PDF
Phenotypic distinctions between mosaic forms of tuberous sclerosis complex
2019 · Alison M. Treichel, Lana Hamieh, et al. · Genetics in Medicine · 38
PDF
Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements
2010 · Jakub Mieczkowski, Magdalena E Tyburczy, et al. · BMC Bioinformatics · 34
PDF
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile
2020 · Krinio Giannikou, Zachary Zhu, et al. · Modern Pathology · 28
PDF
A genome-wide association study implicatesNR2F2in lymphangioleiomyomatosis pathogenesis
2019 · Wonji Kim, Krinio Giannikou, et al. · European Respiratory Journal · 22
Apparent Sporadic Lymphangioleiomyomatosis in a Man as a Result of Extreme Mosaicism for a TSC2 Mutation
2017 · MeiLan K. Han, Magdalena E. Tyburczy, et al. · Annals of the American Thoracic Society · 16
Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase
2015 · Anna R. Malik, Ewa Liszewska, et al. · Acta Neuropathologica Communications · 15
PDF
Nipple Angiofibromas with Loss of TSC2 Are Associated with Tuberous Sclerosis Complex
2015 · Neera Nathan, Magdalena E. Tyburczy, et al. · Journal of Investigative Dermatology · 9
Correction: Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission
2020 · Krinio Giannikou, Kathryn D. Lasseter, et al. · Genetics in Medicine · 7
PDF
Potential clinical applications of circulating tumor DNA in patients with diffuse large B-cell lymphoma
2025 · Magdalena Ewa Tyburczy, Przemysław Juszczyński · Acta Haematologica Polonica · 1
PDF
Subependymal Giant Cell Astrocytoma: Gene Expression Profiling
2011 · Magdalena Ewa Tyburczy, Bozena Kaminska · Springer eBooks · 1
New technologies in the genomic evaluation of lymphomas
2026 · Magdalena Tyburczy · Polish Journal of Pathology
PDF
Table S3 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2023 · David J. Kwiatkowski, Toni K. Choueiri, et al.
PDF
Table S2 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2023 · David J. Kwiatkowski, Toni K. Choueiri, et al.
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2023 · David J. Kwiatkowski, Toni K. Choueiri, et al.
PDF
Table S2 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2023 · David J. Kwiatkowski, Toni K. Choueiri, et al.
PDF
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2023 · David J. Kwiatkowski, Toni K. Choueiri, et al.
Table S4 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
2023 · David J. Kwiatkowski, Toni K. Choueiri, et al.
PDF
Works count: 35
Citation count: 1,182
H-index: 14
I10-index: 14
Year
Topic
Type